According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.
top of page
it's where dermatology lives
More Publications by © Chronicle Companies
Publishers of: The Chronicle of Skin & Allergy; Skin Spectrum Quarterly;
Women in Dermatology; The Chronicle of Cosmetic Medicine + Surgery
www.chronicle.ca www.derm.city www.skinspectrum.ca
© Chronicle Companies 2023
bottom of page
Comments